Evidence map›Paper›PMID 33003552›Full record

ReviewAntioxidants (Basel, Switzerland)2020

Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression.

Jesús Beltrán-García, Rebeca Osca-Verdegal, Federico V Pallardó, José Ferreres, María Rodríguez, Sandra Mulet, Fabian Sanchis-Gomar, Nieves Carbonell, José Luis García-Giménez

Open access · goldAbstract readReview
In one paragraph

Review in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 2 pooled it
3.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 2 syntheses or guidelines pooled it, 154 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Review
  7. Impact of COVID-19 Booster Vaccination on Serum Redox Homeostasis.International journal of molecular sciences · 2026
    Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. COVID-19: a vascular nightmare unfolding.Frontiers in immunology · 2025
    Review
  17. Article
  18. Review
  19. Article
  20. Clinical phenotypes of sepsis: a narrative review.Journal of thoracic disease · 2024
    Review

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jesús Beltrán-GarcíaCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, 46010 Valencia, Spain.
Rebeca Osca-VerdegalDepartment of Physiology, Faculty of Medicine & Dentistry, University of Valencia, 46010 Valencia, Spain.
Federico V PallardóCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, 46010 Valencia, Spain.ORCID 0000-0003-3715-1980
José FerreresINCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
María RodríguezINCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Sandra MuletINCLIVA Biomedical Research Institute, 46010 Valencia, Spain.
Fabian Sanchis-GomarDepartment of Physiology, Faculty of Medicine & Dentistry, University of Valencia, 46010 Valencia, Spain.ORCID 0000-0003-0424-4208
Nieves CarbonellINCLIVA Biomedical Research Institute, 46010 Valencia, Spain.ORCID 0000-0002-9149-0310
José Luis García-GiménezCenter for Biomedical Network Research on Rare Diseases (CIBERER), Institute of Health Carlos III, 46010 Valencia, Spain.ORCID 0000-0001-7547-7872
Universitat de València · ESHospital Clínico Universitario de Valencia · ES

Funding

Instituto de Salud Carlos III IFI18/00015Instituto de Salud Carlos III PI19/00994
6 · The paper itself

Abstract

Since the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outbreak emerged, countless efforts are being made worldwide to understand the molecular mechanisms underlying the coronavirus disease 2019 (COVID-19) in an attempt to identify the specific clinical characteristics of critically ill COVID-19 patients involved in its pathogenesis and provide therapeutic alternatives to minimize COVID-19 severity. Recently, COVID-19 has been closely related to sepsis, which suggests that most deceases in intensive care units (ICU) may be a direct consequence of SARS-CoV-2 infection-induced sepsis. Understanding oxidative stress and the molecular inflammation mechanisms contributing to COVID-19 progression to severe phenotypes such as sepsis is a current clinical need in the effort to improve therapies in SARS-CoV-2 infected patients. This article aims to review the molecular pathogenesis of SARS-CoV-2 and its relationship with oxidative stress and inflammation, which can contribute to sepsis progression. We also provide an overview of potential antioxidant therapies and active clinical trials that might prevent disease progression or reduce its severity.

Indexed as

ACE2cytokine stormNETosispyroptosisSARS-CoV-2sepsis

Identifiers

PMID33003552
PMCPMC7599810
OpenAlexW3089308832

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.